Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
FASEB Bioadvances|July 4, 2020
Low bone mineral density due to secondary hyperparathyroidism in the Gla mouse model of Fabry diseaseHiroki Maruyama, Atsumi Taguchi, Mariko Mikame, et al.
Biomedicines|February 25, 2022
Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical OutcomesChisato Ohe, Takashi Yoshida, Junichi Ikeda, et al.
The American Journal of Surgical Pathology|March 9, 2026
Clear Cell Papillary Renal Cell Tumor Revisited: Comparison of Histologic and Immunohistochemical Profiles in Relation to VHL Allelic StatusKanako Sagan, Fumiyoshi Kojima, Ibu Matsuzaki, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 1, 2021
Development and validation of a vascularity-based architectural classification for clear cell renal cell carcinoma: correlation with conventional pathological prognostic factors, gene expression patterns, and clinical outcomesChisato Ohe, Takashi Yoshida, Mahul B Amin, et al.
Molecular Therapy. Nucleic Acids|January 6, 2016
Effective Prevention of Liver Fibrosis by Liver-targeted Hydrodynamic Gene Delivery of Matrix Metalloproteinase-13 in a Rat Liver Fibrosis ModelHiroyuki Abe, Kenya Kamimura, Yuji Kobayashi, et al.
Cellular Immunology|November 30, 2007
Lipopolysaccharide induced expression of pentraxin 3 in human neutrophils and monocyte-derived macrophagesMasaru Imamura, Takashi Kawasaki, Alexander S Savchenko, et al.
Internal Medicine (Tokyo, Japan)|February 16, 2012
Hypogammaglobulinemic patient with polyarthritis mimicking rheumatoid arthritis finally diagnosed as septic arthritis caused by Mycoplasma hominisHiroe Sato, Noriaki Iino, Riuko Ohashi, et al.
Plos One|April 13, 2019
Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutationsMiyuki Sato, Satoshi Watanabe, Hiroshi Tanaka, et al.
Pathology International|September 7, 2007
PIK3CA mutation and amplification in human lung cancerKoji Okudela, Masaya Suzuki, Shinji Kageyama, et al.
Human Pathology|February 29, 2024
Mucin phenotype and genetic alterations in non-V600E BRAF-mutated colorectal cancerHikaru Ozeki, Yoshifumi Shimada, Mae Nakano, et al.
Pageof 9